1
0
0
News
Microarray-based gene expression analysis for the investigation of...
publikationen.uni-tuebingen.de
... der Fakultät für Chemie und Pharmazie der Eberhard-Karls-Universität Tübingen zur Erlangung des Grades eines Doktors der Naturwissenschaften vorgelegt von Oliver Schoor
onkoserv - der aktuellste und unabhängige deutsche Informationsdienst...
www.onkoserv.de
Onkoserv ist der aktuellste deutsche Informationsdienst für die klinische Onkologie
Netzwerk-Profile
Interessen
Oliver SCHOOR - Patents
www.freshpatents.com
Recent bibliographic sampling of Oliver SCHOOR patents listed/published in the public domain by the USPTO (USPTO Patent Application #,Title):
Business-Profile
patentbuddy: Oliver Schoor
IMMATICS BIOTECHNOLOGIES GMBH, Tuebingen, DE
Besitz
US Peptides and combination of peptides for use in...
patentscope.wipo.int
This patent search tool allows you not only to search the PCT database of about 2 million International Applications but also the worldwide patent collections....
Bücher
Oliver Schoor | XanEdu Customization Platform
www.academicpub.com
Author: Oliver Schoor. Results. Autophagy in innate and adaptive immunity against intracellular pathogens Springer Science+Business Media
AACR 2016: Abstracts American Association for Cancer...
books.google.de
The AACR Annual Meeting is a must-attend event for cancer researchers and the broader cancer community. This year's theme, "Delivering Cures Through...
AACR Proceedings: Abstracts American Association for...
books.google.de
The AACR Annual Meeting highlights the best cancer science and medicine from institutions all over the world. Attendees are invited to stretch their...
Microarray-based Gene Expression Analysis for the Investigation of...
books.google.de
Oliver Schoor pages. 0 Reviewshttp://books.google.com/books/about/Microarray_based_Gene_Expression_Analysi.html?id=Um_DnAEACAAJ ...
Dokumente zum Namen
EBSCOhost | | Production and characterization of amplified...
web.a.ebscohost.com
, Tübingen, Germany. Email: Jean-Philippe Carralot - ; Benjamin Weide - -tuebingen.de; Oliver Schoor - oliver.schoor@uni- tuebingen.de; Jochen Probst - -tuebingen.de; Birgit Scheel - ; Regina ...
Lessons to be learned from primary renal cell carcinomas: novel tumor...
www.proquest.com
Tobias Kru¨ger Æ Oliver Schoor Æ Claudia Lemmel. Bjoern Kraemer Æ Christian Reichle Æ Jo¨rn Dengjel. Toni Weinschenk Æ Margret ...
Moderate degradation does not preclude microarray analysis of small...
www.scienceopen.com
Gene expression analysis by microarrays using small amounts of RNA is becoming more and more popular against the background of advances and...
Natural HLA class I ligands from glioblastoma: extending the options...
www.proquest.com
Marian Christoph Neidert • Oliver Schoor • Claudia Trautwein •. Nico Trautwein • Lisa Christ • Arthur Melms • Jürgen Honegger •. Hans-Georg ...
Wissenschaftliche Veröffentlichungen
Kidney cancer vaccine successful in clinical trials -- ScienceDaily
www.sciencedaily.com
Researchers have completed two successful clinical studies using the kidney-cancer vaccine IMA901.
Possibilities for personalized vaccines -- ScienceDaily
www.sciencedaily.com
Medical researchers are considering the possibilities for personalized vaccines in all types of cancer. The first vaccine will be prepared from a warehouse of...
Veröffentlichungen allgemein
Lessons to be learned from primary renal cell carcinomas: novel tumor...
link.springer.com
The lack of sufficient well-defined tumor-associated antigens is still a drawback on the way to a cytotoxic T-lymphocyte-based immunotherapy of renal cell
Immunotherapy for brain tumors - GEINO
www.geino.es
Oliver Schoor. Toni Weinschenk. Harpreet Singh. Jennifer Lohr. Judith Bucher. Katharina Dorsch. Christel Herold-Mende. Translational Immunology Unit.
Sonstiges
EP A1 - Novel immunotherapy against neuronal and brain tumors...
patents.google.com
Oppfinnere, Norbert Hilf, Oliver Schoor, Harpreet Singh, Claudia Trautwein, Steffen Walter, Toni Weinschenk. Søker, Immatics Biotechnologies GmbH. Eksporter ...
Oliver Schoor's research works | Immatics Biotechnologies ...www.researchgate.net › scientific-contributions › Oliver-Schoor
www.researchgate.net
Oliver Schoor's 62 research works with citations and reads, including: Pitfalls in HLA ligandomics – How to catch a li(e)gand.Chybí: Sierksdorf" | Musí obsahovat:Sierksdorf" Oliver Schoor's 62 research works with citations and reads, including: Pitfalls in HLA ligandomics – How to catch a li(e)gand. Chybí: Sierksdorf" | Musí obsahovat:Sierksdorf"
Oliver Schoor, Ph.D. - Immaticsimmatics.com › portfolio › oliver-schoor-ph-d
immatics.com
Vice President Target Research. Oliver Schoor joined Immatics in and heads the Target Research Department dedicated to target discovery and validation.Chybí: Sierksdorf" | Musí obsahovat:Sierksdorf" Vice President Target Research. Oliver Schoor joined Immatics in and heads the Target Research Department dedicated to target discovery and validation. Chybí: Sierksdorf" | Musí obsahovat:Sierksdorf"
Renal Cell Carcinoma: Schoor, Oliver - Expertscape.com
www.expertscape.com
Oliver Schoor has special expertise in Carcinoma, Renal Cell
(11) PL/EP PL/EP T3 - Urząd Patentowy ...
pubserv.uprp.pl
(73) Uprawniony z patentu: Immatics Biotechnologies GmbH, Tübingen, DE. (72) Twórca(y) wynalazku: OLIVER SCHOOR, Tübingen, DE.
CiteSeerX — A cryptic vascular endothelial growth factor T-cell...
citeseerx.ist.psu.edu
by Andreas O. Weinzierl , Dominik Maurer , Florian Altenberend , Nicole Schneiderhan-marra , Karin Klingel , Oliver Schoor , Dorothee Wernet , Thomas Joos ...
GMS | 64th Annual Meeting of the German Society of...
www.egms.de
Marian Christoph Neidert - Institut für Immunologie, Institut für Zellbiologie, Eberhard-Karls-Universität, Tübingen; Oliver Schoor - immatics biotechnologies GmbH, Tübingen; Claudia Trautwein - immatics biotechnologies GmbH, Tübingen; Nico Trautwein - Institut für Immunologie, Institut für Zellbiologie, ...
Autophagy promotes MHC class II presentation of peptides from...
research.kssg.ch
Jörn Dengjel, Oliver Schoor, Rainer Fischer, Michael Reich, Marianne Kraus, Margret Müller, Katharina Kreymborg, Florian Altenberend, Jens Brandenburg, ...
Neue Angriffspunkte für Impfung gegen Hirntumor
mensch-und-krebs.de
Valerie Dutoit, Christel Herold-Mende, Norbert Hilf, Oliver Schoor, Philipp Beckhove, Judith Bucher, Katharina Dorsch, Sylvia Flohr, Jens Fritsche, Peter Lewandrowski, Jennifer Lohr, Hans-Georg Rammensee, Stefan Stevanovic, Claudia Trautwein, Verona Vass, Steffen Walter, Paul R. Walker, Toni Weinschenk, Harpreet ...
Schoor, DE - Patent applications
www.patentsencyclopedia.com
Patent application number Description Published; : NOVEL IMMUNOTHERAPY ... Patent applications by Oliver Schoor, Tubingen DE
Cutting Edge: Predetermined Avidity of Human CD8 T Cells Expanded on...
www.jimmunol.org
Steffen Walter *, Leah Herrgen *, Oliver Schoor *, Gundram Jung *, Dorothee Wernet †
Tumour-associated peptides binding to MHC-molecules - Patent...
www.patentsencyclopedia.com
... Aichwald, DE) Claudia Lemmel (Tubingen, DE) Claudia Lemmel (Tübingen, DE) Jörg Dengjel (Odense, DK) Jörg Dengjel (Odense, DK) Oliver Schoor (Tülebingen, DE) Oliver Schoor
NOVEL IMMUNOTHERAPY AGAINST NEURONAL AND BRAIN TUMORS - Patent...
www.patentsencyclopedia.com
Patent application title: NOVEL IMMUNOTHERAPY AGAINST NEURONAL AND BRAIN TUMORS Inventors: Toni Weinschenk (Aichwald, DE) Oliver Schoor (Tubingen, DE) Claudia
Verwandte Suchanfragen zu Oliver Schoor
| Christoph Neidert Dominik Maurer Florian Altenberend | Jens Fritsche Norbert Hilf Nina Pawlowski |
Personen Vorname "Oliver" (42674) Name "Schoor" (172) |
sortiert nach Relevanz / Datum